Recent Posts

Credit Suisse finds ‘material’ control lapses after SEC check

BLOOMBERG Credit Suisse Group said it found “material weaknesses” in its reporting and control procedures for the past two years, after questions from US regulators. The Zurich-based bank said it will take steps to fix ineffective checks on the process it follows to pull together its financial reports. But the firm said its statements for 2022 and 2021 “fairly present” ...

Read More »

VW sets $193b spending plan to further new technology

BLOOMBERG Volkswagen AG boosted its five-year investment plan to €180 billion ($193 billion) as Europe’s biggest carmaker intensifies a push to challenge Tesla Inc’s leadership on electric vehicles (EV).  More than two-thirds of the total — €122 billion — will go to software and electric vehicles, the company said. The previous update of VW’s rolling investment saw the carmaker invest ...

Read More »

Novartis starts sale of ophthalmology assets

BLOOMBERG Novartis AG is kicking off the sale of some ophthalmology assets, people with knowledge of the matter said, as it seeks to prune its portfolio and focus on growth areas. The Swiss pharmaceuticals group is working with an adviser to gauge interest in the so-called front-of-eye treatments, the people said. The portfolio includes Xiidra, a drug used to treat ...

Read More »
Send this to a friend